Bruno, Savino
 Distribuzione geografica
Continente #
NA - Nord America 1.613
EU - Europa 579
AS - Asia 238
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 2.434
Nazione #
US - Stati Uniti d'America 1.607
GB - Regno Unito 176
IT - Italia 120
DE - Germania 92
SG - Singapore 83
SE - Svezia 82
CN - Cina 55
HK - Hong Kong 38
TR - Turchia 27
FI - Finlandia 25
IN - India 23
UA - Ucraina 22
RU - Federazione Russa 14
BG - Bulgaria 13
BE - Belgio 10
FR - Francia 8
ID - Indonesia 6
CA - Canada 4
LT - Lituania 3
AL - Albania 2
BZ - Belize 2
CZ - Repubblica Ceca 2
MY - Malesia 2
NL - Olanda 2
PL - Polonia 2
RO - Romania 2
ZA - Sudafrica 2
AM - Armenia 1
AT - Austria 1
AU - Australia 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
PT - Portogallo 1
Totale 2.434
Città #
Fairfield 250
Santa Clara 167
Chandler 143
Southend 139
Woodbridge 134
Ashburn 133
Seattle 112
Houston 98
Wilmington 82
Cambridge 72
Singapore 70
Ann Arbor 68
Modena 68
Nyköping 60
Dearborn 41
Hong Kong 38
Jacksonville 32
Helsinki 24
Izmir 24
New York 20
San Diego 17
Bremen 14
Princeton 13
Sofia 13
Grafing 11
Brussels 10
Beijing 8
Des Moines 8
Eugene 8
Redwood City 8
Shanghai 7
Jakarta 6
Munich 6
London 5
Moscow 5
Augusta 4
Naples 4
Rome 4
Boardman 3
Chicago 3
Fremont 3
Los Angeles 3
Monmouth Junction 3
Mumbai 3
San Mateo 3
Belize City 2
Brno 2
Cardano al Campo 2
Dallas 2
Falkenstein 2
Jinan 2
Kilburn 2
Lanzhou 2
Leawood 2
Muizenberg 2
Phoenix 2
Acton 1
Amsterdam 1
Apo 1
Ardabil 1
Ascoli Piceno 1
Baoding 1
Baotou 1
Birmingham 1
Citta 1
Cividale Del Friuli 1
Clearwater 1
Dalian 1
Dublin 1
Guayaquil 1
Hangzhou 1
Indiana 1
Islington 1
Lisbon 1
Markham 1
Milan 1
Modesto 1
Montefiore Conca 1
Montréal 1
Nanning 1
Napoli 1
Novokuznetsk 1
Nuremberg 1
Ottawa 1
Padova 1
Pontevedra 1
Prescot 1
Reggio Emilia 1
Reggio Nell'emilia 1
Rho 1
San Francisco 1
Shaoxing 1
Shenyang 1
Shenzhen 1
Sydney 1
Targu 1
Tokyo 1
Torino 1
Toronto 1
Vienna 1
Totale 2.013
Nome #
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 320
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 292
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 291
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 217
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 214
From current status to optimization of HCV treatment: Recommendations from an expert panel 180
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 176
Current and future challenges in HCV: insights from an Italian experts panel 168
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 141
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 136
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 135
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 95
Preoperative Risk Factors for Access Site Failure in Ultrasound-Guided Percutaneous Treatment of TASC C and D Aorto-Iliac Occlusive Disease 57
Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study 45
Totale 2.467
Categoria #
all - tutte 10.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 0 0 0 61 33 41 15 21 7
2020/2021639 29 15 41 49 97 61 138 50 27 70 48 14
2021/2022305 20 22 9 19 7 24 20 27 31 33 62 31
2022/2023351 46 48 33 39 42 48 8 34 29 0 11 13
2023/2024192 5 12 15 21 26 22 20 20 7 5 11 28
2024/2025308 17 1 14 53 129 92 2 0 0 0 0 0
Totale 2.467